FindMyKOL

Vijay Balasubramanian, MD

Basic profile

Pulmonary Disease

ORCID↗NPI↗
✓ Full record
RegionFresno, CA · WestSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLFindMyKOL type: RegionalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Vijay Balasubramanian is a Respiratory physician. OpenAlex indexes 79 publications with 520 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
79publications

Distinct works indexed by OpenAlex, matched via ORCID.

520citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
25companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2335 E Kashian Ln Ste 260
Fresno, CA 937012234

Telephone

559-256-5130

Provider last certified this registry record 3 Aug 2022.

View the NPPES registry record

Industry payments

25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    31.3%
    Corticosteroid20.8%
    Trelegy Ellipta62%Breo Ellipta15%Breztri Aerosphere14%Fluticasone Propionate9%
    Part D<11 patients
    beta2-Adrenergic Agonist10.5%
    Albuterol Sulfate Hfa100%
    Part D≥39 patients
  • Cardiovascular

    15.4%
    Endothelin Receptor Antagonist7.6%
    Opsumit49%Letairis25%Ambrisentan25%
    Part D<11 patients
    Loop diuretic4.9%
    Furosemide100%
    Part D≥14 patients

    + 1 more class in this area

  • Genitourinary & hormones

    13.2%
    Phosphodiesterase 5 Inhibitor13.2%
    Tadalafil79%Sildenafil Citrate21%
    Part D<11 patients
Where care is delivered (Part B)28.6% facility · 71.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”